104 related articles for article (PubMed ID: 9629565)
1. Effects of clozapine on in vitro immune parameters: a longitudinal study in clozapine-treated schizophrenic patients.
Hinze-Selch D; Becker EW; Stein GM; Berg PA; Mullington J; Holsboer F; Pollmächer T
Neuropsychopharmacology; 1998 Aug; 19(2):114-22. PubMed ID: 9629565
[TBL] [Abstract][Full Text] [Related]
2. [Clozapine, cytokines, fever and sleep].
Hinze-Selch D; Mullington J; Pollmächer T
Wien Med Wochenschr; 1996; 146(13-14):311-3. PubMed ID: 9012164
[TBL] [Abstract][Full Text] [Related]
3. In vivo immunomodulatory effects of clozapine in schizophrenia.
Maes M; Bosmans E; Kenis G; De Jong R; Smith RS; Meltzer HY
Schizophr Res; 1997 Aug; 26(2-3):221-5. PubMed ID: 9323354
[TBL] [Abstract][Full Text] [Related]
4. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders.
Igue R; Potvin S; Bah R; Stip E; Bouchard RH; Lipp O; Gendron A; Kouassi E
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1695-8. PubMed ID: 21627977
[TBL] [Abstract][Full Text] [Related]
5. Effects of clozapine on plasma cytokine and soluble cytokine receptor levels.
Pollmächer T; Hinze-Selch D; Mullington J
J Clin Psychopharmacol; 1996 Oct; 16(5):403-9. PubMed ID: 8889915
[TBL] [Abstract][Full Text] [Related]
6. Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine.
Maes M; Meltzer HY; Bosmans E
Acta Psychiatr Scand; 1994 May; 89(5):346-51. PubMed ID: 8067274
[TBL] [Abstract][Full Text] [Related]
7. [Effect of clozapine and risperidone on serum cytokine levels in patients with first-episode paranoid schizophrenia].
Lü LX; Guo SQ; Chen W; Li Q; Cheng J; Guo JH
Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1251-4. PubMed ID: 15567770
[TBL] [Abstract][Full Text] [Related]
8. Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice.
Sugino H; Futamura T; Mitsumoto Y; Maeda K; Marunaka Y
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):303-7. PubMed ID: 19138716
[TBL] [Abstract][Full Text] [Related]
9. Renal cell carcinoma-associated immune impairment that may interfere with the response to cytokine therapy.
Lauerová L; Dusek L; Simícková M; Rovný F; Spurný V; Rovný A; Slampa P; Zaloudík J; Rejthar A; Wotke J; Kovarík J
Neoplasma; 1999; 46(3):141-9. PubMed ID: 10613588
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment.
Monteleone P; Fabrazzo M; Tortorella A; Maj M
Psychiatry Res; 1997 Jun; 71(1):11-7. PubMed ID: 9247977
[TBL] [Abstract][Full Text] [Related]
11. The influence of clozapine treatment on plasma granulocyte colony-stimulating (G-CSF) levels.
Pollmächer T; Fenzel T; Mullington J; Hinze-Selch D
Pharmacopsychiatry; 1997 Jul; 30(4):118-21. PubMed ID: 9271776
[TBL] [Abstract][Full Text] [Related]
12. Lipid status, anti-oxidant enzyme defence and haemoglobin content in the blood of long-term clozapine-treated schizophrenic patients.
Miljevic C; Nikolic M; Nikolic-Kokic A; Jones DR; Niketic V; Lecic-Tosevski D; Spasic MB
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):303-7. PubMed ID: 19962416
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive effects of clozapine and haloperidol: enhanced production of the interleukin-1 receptor antagonist.
Song C; Lin Ah; Kenis G; Bosmans E; Maes M
Schizophr Res; 2000 Apr; 42(2):157-64. PubMed ID: 10742653
[TBL] [Abstract][Full Text] [Related]
14. Correlations of Kynurenic Acid, 3-Hydroxykynurenine, sIL-2R, IFN-α, and IL-4 with Clinical Symptoms During Acute Relapse of Schizophrenia.
Szymona K; Zdzisińska B; Karakuła-Juchnowicz H; Kocki T; Kandefer-Szerszeń M; Flis M; Rosa W; Urbańska EM
Neurotox Res; 2017 Jul; 32(1):17-26. PubMed ID: 28275903
[TBL] [Abstract][Full Text] [Related]
15. Effect of coadministration of clozapine and fluvoxamine versus clozapine monotherapy on blood cell counts, plasma levels of cytokines and body weight.
Hinze-Selch D; Deuschle M; Weber B; Heuser I; Pollmächer T
Psychopharmacology (Berl); 2000 Apr; 149(2):163-9. PubMed ID: 10805611
[TBL] [Abstract][Full Text] [Related]
16. Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics.
Grillo RW; Ottoni GL; Leke R; Souza DO; Portela LV; Lara DR
J Psychiatr Res; 2007; 41(1-2):31-5. PubMed ID: 16546213
[TBL] [Abstract][Full Text] [Related]
17. The influence of typical and atypical neuroleptic drugs in the production of interleukin-2 and interferon-gamma in vitro.
Rudolf S; Peters M; Rothermundt M; Arolt V; Kirchner H
Neuropsychobiology; 2002; 46(4):180-5. PubMed ID: 12566934
[TBL] [Abstract][Full Text] [Related]
18. Neuroleptics modulate cytokine and reactive oxygen species production in blood leukocytes of healthy volunteers.
Szuster-Ciesielska A; Słotwińska M; Stachura A; Marmurowska-Michałowska H; Kandefer-Szerszeń M
Arch Immunol Ther Exp (Warsz); 2004; 52(1):59-67. PubMed ID: 15053234
[TBL] [Abstract][Full Text] [Related]
19. Pro-inflammatory cytokine levels are raised in female schizophrenia patients treated with clozapine.
O'Connell KE; Thakore J; Dev KK
Schizophr Res; 2014 Jun; 156(1):1-8. PubMed ID: 24742875
[TBL] [Abstract][Full Text] [Related]
20. Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor.
Maes M; Bocchio Chiavetto L; Bignotti S; Battisa Tura GJ; Pioli R; Boin F; Kenis G; Bosmans E; de Jongh R; Altamura CA
Schizophr Res; 2002 Apr; 54(3):281-91. PubMed ID: 11950553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
